HDAC function is closely involved in angiogenesis and tumour progression through control of hypoxia-responsive genes, and HDAC inhibitors have the potential to inhibit angiogenesis, by altering the balance between pro- and anti-angiogenic factors [46–49]. Here, HDAC9 is linked to neoplasm.